Although the frequency of CVP-related complications tended to be higher in the Bmab-containing CTx group compared to the Bmab-free group (p = 0.022), there were no significant differences in the incidences of venous thrombosis between the two groups (p = 0.4119). Here, CYP27A1 is linked to Venous thrombosis.